Premium
Spotlight Commentary – Voxelotor: A new kid on the block in the treatment of sickle cell disease
Author(s) -
Çanak Betül,
Eşkazan Ahmet Emre
Publication year - 2022
Publication title -
british journal of clinical pharmacology
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 1.216
H-Index - 146
eISSN - 1365-2125
pISSN - 0306-5251
DOI - 10.1111/bcp.15249
Subject(s) - hydroxycarbamide , medicine , adverse effect , reticulocytosis , disease , pharmacology , anemia